検索結果 - Emmanuelle Tresch-Bruneel
- 検索結果 1 - 3 結果 / 3
-
1
Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO) 著者: Emmanuelle Bompas, Axel Le Cesne, Emmanuelle Tresch-Bruneel, Loïc Lebellec, Valérie Laurence, Olivier Collard, Esma Saâda-Bouzid, Nicolás Isambert, Jean‐Yves Blay, Éric Amela, Sébastien Salas, Christine Chevreau, François Bertucci, Antoîne Italiano, Stéphanie Clisant, Nicolas Penel
出版事項 2015Artigo -
2
<scp>REGOSARC</scp>: Regorafenib versus placebo in doxorubicin‐refractory soft‐tissue sarcoma—A quality‐adjusted time without symptoms of progression or toxicity analysis 著者: Vincent Berry, Laurent Basson, Emilie Bogart, Olivier Mir, Jean‐Yves Blay, Antoîne Italiano, François Bertucci, Christine Chevreau, Stéphanie Clisant‐Delaine, Bernadette Liegl‐Antzager, Emmanuelle Tresch-Bruneel, Jennifer Wallet, S. Taïeb, Emilie Decoupigny, Axel Le Cesne, Thomas Brodowicz, Nicolas Penel
出版事項 2017Artigo -
3
Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial 著者: Isabelle Laure Ray-Coquard, Julien Dômont, Emmanuelle Tresch-Bruneel, Emmanuelle Bompas, Philippe A. Cassier, Olivier Mir, Sophie Piperno‐Neumann, Antoîne Italiano, Christine Chevreau, Didier Cupissol, François Bertucci, Jacques‐Olivier Bay, Olivier Collard, Esma Saâda-Bouzid, Nicolás Isambert, Corinne Delcambre, Stéphanie Clisant, Axel Le Cesne, Jean‐Yves Blay, Nicolas Penel
出版事項 2015Artigo
関連主題
Internal medicine
Medicine
Surgery
Chemotherapy
Clinical endpoint
Confidence interval
Gastroenterology
Oncology
Progression-free survival
Adverse effect
Alternative medicine
Bevacizumab
Cancer
Clinical trial
Colorectal cancer
Expanded access
Hazard ratio
Hepatocellular carcinoma
Paclitaxel
Pathology
Phases of clinical research
Placebo
Progressive disease
Radiation therapy
Randomized controlled trial
Regorafenib
Response Evaluation Criteria in Solid Tumors
Sarcoma
Soft tissue sarcoma
Sorafenib